sodium channels
3 drugs Cardiovascular
5
approved indications
3
Approved Drugs
3
Companies
6
Indications
1
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (3 companies)
✓ All 3 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (6 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
GLENMARK PHARMS LTD 1 drug
Pfizer 1 drug
Novartis 1 drug
By Therapeutic Area
Cardiovascular 2 drugs
Other 1 drugs
Drugs by Company PRO
GLENMARK PHARMS LTD 1 drug
Pfizer 1 drug
Novartis 1 drug
By Therapeutic Area
Cardiovascular 2 drugs
PROPAFENONE HYDROCHLORIDE, CORVERT
Other 1 drugs
TRILEPTAL
Indications Treated
Atrial FibrillationAtrial FlutterSupraventricular TachycardiaVentricular TachycardiaVentricular ArrhythmiasPartial-Onset Seizures
All Drugs Targeting sodium channels
| Drug | Company | Approved | Indications | Therapeutic Area |
|---|---|---|---|---|
| PROPAFENONE HYDROCHLORIDE | GLENMARK PHARMS LTD | 2000 | 5 | Cardiovascular |
| CORVERT | Pfizer | 1995 | 2 | Cardiovascular |
| TRILEPTAL | Novartis | 2000 | 1 |